There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
127.14 Cr.Face value
10.00Book value
-74.60Div. yield
0.000P/E ratio
0.00P/B ratio
0.00Debt/Eq.
-Market Cap
127.14 Cr.Face value
10.00Book value
-74.60Div. yield
0.00%P/E ratio
0.00P/B ratio
0.00Debt/Eq.
-
| Dec 25 | Sep 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 72.74% | 72.74% | 0.00% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
Krebs Biochemicals & Industries Limited (KBIL) is an India-based company. The Company operates in the pharma segment. The Company’s products include lavastatin simvastatin and simvastatin ammonium salt. The Company specializes in the fermentation te 
Krebs Biochemicals & Industries Limited manufactures active pharmaceutical ingredients (APIs) and operates as a single-segment Pharma company, with no separate geographical reporting.
The Company operates two units in Andhra Pradesh: Unit I: Regadichelika (Kodavalur Mandal), Nellore District Unit II: Kothapalli (Kasimkota Mandal), Anakapalli, Visakhapatnam District
No. The Company has no subsidiaries, associates, or joint ventures as of March 31, 2025.
